Avid Bioservices Inc (CDMO)

[Protector]

stoneroad, that would be a good strategy. However, PPHM with all what is going on may not have the luxury to xeight.

Avid II will have costed millions, SUNRISE may have been paid for mainly and Bavi is storage ready, but still the BLA, result analyses and possible CRO invoices will keep coming at some extend, starting new clinical trials, attending conferences, etc.

And they must keep a certain cash level to avoid going concerns too.

So, yes, let the pps go up if you can, be can they?